64. 血栓性血小板減少性紫斑病 Thrombotic thrombocytopenic purpura Clinical trials / Disease details

臨床試験数 : 86 / 薬物数 : 81 - (DrugBank : 20) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 63

26 trials found

diseases per page:

Showing 1 to 10 of 26 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04074187 (ClinicalTrials.gov)	October 21, 2019	14/8/2019	A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP ...	An Open-label Multicenter Trial to Study the Efficacy and Safety of Caplacizumab in Japanese Patient ...	Thrombotic Thrombocytopenic Purpura	Drug: Caplacizumab (ALX-0081);Drug: Plasma exchange (PE);Drug: Corticosteroid treatment (Methylpredni ...	Sanofi	NULL	Completed	18 Years	N/A	All	21	Phase 2/Phase 3	Japan
2	EUCTR2016-001503-23-NL (EUCTR)	05/07/2017	19/07/2017	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Not Recruiting			Female: yes Male: yes	92	Phase 3	United States;Spain;Turkey;Austria;Israel;Italy;Switzerland;United Kingdom;France;Hungary;Czech Repu ...
3	EUCTR2016-001503-23-DE (EUCTR)	12/04/2017	03/01/2017	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 19.1;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Not Recruiting			Female: yes Male: yes	92	Phase 3	United States;Spain;Turkey;Austria;Israel;Italy;Switzerland;United Kingdom;France;Czech Republic;Hun ...
4	EUCTR2016-001503-23-FR (EUCTR)	07/02/2017	20/10/2016	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 19.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Not Recruiting			Female: yes Male: yes	92	Phase 3	United States;Spain;Turkey;Austria;Israel;United Kingdom;Italy;Switzerland;France;Czech Republic;Hun ...
5	EUCTR2016-001503-23-GB (EUCTR)	15/11/2016	15/08/2016	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Not Recruiting			Female: yes Male: yes	104	Phase 3	United States;Spain;Turkey;Austria;Israel;United Kingdom;Italy;Switzerland;France;Czech Republic;Hun ...
6	EUCTR2016-001503-23-CZ (EUCTR)	31/10/2016	19/08/2016	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Not Recruiting			Female: yes Male: yes	104	Phase 3	Spain;Turkey;Austria;Israel;Italy;Switzerland;United Kingdom;France;Czech Republic;Hungary;Canada;Be ...
7	EUCTR2016-001503-23-BE (EUCTR)	21/10/2016	22/08/2016	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	104	Phase 3	United States;Spain;Turkey;Austria;Israel;Switzerland;United Kingdom;Italy;France;Czech Republic;Hun ...
8	EUCTR2016-001503-23-HU (EUCTR)	06/10/2016	10/08/2016	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 19.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Not Recruiting			Female: yes Male: yes	92	Phase 3	United States;Spain;Turkey;Austria;Israel;United Kingdom;Italy;Switzerland;France;Hungary;Czech Repu ...
9	EUCTR2016-001503-23-ES (EUCTR)	25/08/2016	15/07/2016	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 19.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	92	Phase 3	United States;Spain;Turkey;Austria;Israel;Italy;Switzerland;United Kingdom;France;Czech Republic;Hun ...
10	EUCTR2016-001503-23-AT (EUCTR)	16/08/2016	14/07/2016	Follow-up Study for Patients who Completed Study ALX0681-C301 (Post-HERCULES)	Prospective Follow-up Study for Patients who Completed Study ALX0681-C301 (HERCULES) to Evaluate Lon ...	Acquired thrombotic thrombocytopenic purpura (TTP) MedDRA version: 20.0;Level: PT;Classification cod ...	Product Name: Caplacizumab (an anti-von Willebrand Factor Nanobody ALX-0081) Product Code: ALX-0081 INN ...	Ablynx NV	NULL	Not Recruiting			Female: yes Male: yes	104	Phase 3	United States;Spain;Turkey;Austria;Israel;Italy;Switzerland;United Kingdom;France;Czech Republic;Hun ...

First Previous1 2 3Next Last